Ito Yasushi, Takahashi Satoru, Kagitani-Shimono Kuriko, Natsume Jun, Yanagihara Keiko, Fujii Tatsuya, Oguni Hirokazu
Department of Pediatrics, Tokyo Women's Medical University, Japan.
Department of Pediatrics, Asahikawa Medical University, Japan.
Brain Dev. 2015 Sep;37(8):780-9. doi: 10.1016/j.braindev.2014.11.006. Epub 2014 Dec 5.
We conducted a nationwide survey of glucose transporter type-1 deficiency syndrome (GLUT-1DS) in Japan in order to clarify its incidence as well as clinical and laboratory information.
A questionnaire to survey the number of genetically and clinically confirmed cases of GLUT-1DS was sent to 1018 board-certified pediatric neurologists, which resulted in 57 patients being reported. We obtained the clinical and laboratory data of 33 patients through a secondary questionnaire.
The age of the 33 patients (male: 15, female: 18) at the time of the study ranged between 3 and 35 years (mean: 13.5 years). The age of these patients at the onset of initial neurological symptoms ranged between the neonatal period and 48 months (mean: 9.4 months). GLUT-1DS was diagnosed at a mean age of 8.4 years (range: 1 year to 33 years). The initial symptom was convulsive seizures, which occurred in 15 cases, and was followed by abnormal eye movements in 7 cases and apneic or cyanotic attacks in 4 cases. The latter two symptoms most frequently occurred early in infancy. Thirty-two patients (97%) exhibited some type of epileptic seizure. Neurological findings revealed that most patients had muscle hypotonia, cerebellar ataxia, dystonia, and spastic paralysis. Mild to severe mental retardation was detected in all 33 cases. Furthermore, paroxysmal episodes of ataxia, dystonia/dyskinesia, and motor paralysis were described in approximately 1/3 of all patients. The factors that frequently aggravated these events were hunger, exercise, fever, and fatigue, in that order. The mean CSF/blood glucose ratio was 0.36 (0.28-0.48). Pathological mutations in the SLC2A1 gene were identified in 28 out of 32 cases (87.5%).
The results described herein provided an insight into the early diagnosis of GLUT1-DS, including unexplained paroxysmal abnormal eye movements, apneic/cyanotic attacks, and convulsive seizures in infancy, as well as uncommon paroxysmal events (ataxia, atonia, and motor paralysis) in childhood.
我们在日本开展了一项关于1型葡萄糖转运体缺乏综合征(GLUT-1DS)的全国性调查,以明确其发病率以及临床和实验室信息。
向1018名获得认证的儿科神经科医生发送了一份调查问卷,以调查基因和临床确诊的GLUT-1DS病例数量,共报告了57例患者。我们通过二次问卷调查获得了33例患者的临床和实验室数据。
研究时33例患者(男15例,女18例)的年龄在3至35岁之间(平均13.5岁)。这些患者初次出现神经症状的年龄在新生儿期至48个月之间(平均9.4个月)。GLUT-1DS的诊断平均年龄为8.4岁(范围:1岁至33岁)。初始症状为惊厥发作,共15例,其次是7例异常眼动和4例呼吸暂停或青紫发作。后两种症状最常发生在婴儿早期。32例患者(97%)出现某种类型的癫痫发作。神经学检查发现,大多数患者有肌张力低下、小脑共济失调、肌张力障碍和痉挛性瘫痪。所有33例患者均检测出轻度至重度智力发育迟缓。此外,约1/3的患者出现发作性共济失调、肌张力障碍/运动障碍和运动性瘫痪。经常加重这些症状的因素依次为饥饿、运动、发热和疲劳。脑脊液/血糖平均比值为0.36(0.28 - 0.48)。32例中的28例(87.5%)鉴定出SLC2A1基因的病理性突变。
本文所述结果为GLUT1-DS的早期诊断提供了见解,包括婴儿期不明原因的发作性异常眼动、呼吸暂停/青紫发作和惊厥发作,以及儿童期罕见的发作性事件(共济失调、肌张力缺失和运动性瘫痪)。